Literature DB >> 3351524

Aggravation of Parkinson's disease by cinnarizine.

M Fernandez Pardal, J Fernandez Pardal, F Micheli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3351524      PMCID： PMC1032743          DOI： 10.1136/jnnp.51.1.158-c

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Ca2+-dependence of 3H-catecholamines release evoked by black widow spider venom gland extract in rat hypothalamus, occipital cortex and caudate nucleus.

Authors:  J Fernández-Pardal; A R Granata; A Barrio; A L Gimeno
Journal:  Acta Physiol Lat Am       Date:  1983

2.  Aggravation of Parkinson's disease by cinnarizine.

Authors:  J F Martí Massó; J A Obeso; N Carrera; J M Martínez-Lage
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

3.  Flunarizine- and cinnarizine-induced extrapyramidal reactions.

Authors:  F Micheli; M F Pardal; M Gatto; M Torres; G Paradiso; I C Parera; R Giannaula
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910
  3 in total
  4 in total

1.  Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.

Authors:  Hsiu-Li Lin; Hsiu-Chen Lin; Yuan-Fu Tseng; Shih-Chang Chen; Chien-Yeh Hsu
Journal:  Eur J Clin Pharmacol       Date:  2016-12-16       Impact factor: 2.953

Review 2.  Diagnosis and treatment of Parkinson's disease in the elderly.

Authors:  J I Sage; M H Mark
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

Review 3.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.